IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 250 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $440 | -35.3% | 96,618 | 0.0% | 0.00% | -25.0% |
| Q2 2023 | $680 | +15.3% | 96,618 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $590 | -9.0% | 96,618 | -4.7% | 0.00% | -20.0% |
| Q4 2022 | $648 | -99.9% | 101,374 | -5.5% | 0.01% | -37.5% |
| Q3 2022 | $1,027,000 | +97.1% | 107,249 | +127.2% | 0.01% | +100.0% |
| Q2 2022 | $521,000 | -33.7% | 47,210 | 0.0% | 0.00% | -20.0% |
| Q1 2022 | $786,000 | -14.3% | 47,210 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $917,000 | -21.2% | 47,210 | 0.0% | 0.01% | -16.7% |
| Q3 2021 | $1,164,000 | +97.3% | 47,210 | +108.3% | 0.01% | +50.0% |
| Q2 2021 | $590,000 | -17.8% | 22,666 | 0.0% | 0.00% | -20.0% |
| Q1 2021 | $718,000 | – | 22,666 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 2,222,701 | $25,005,000 | 8.92% |
| Broadfin Capital, LLC | 4,894,361 | $55,062,000 | 8.10% |
| GREAT POINT PARTNERS LLC | 3,496,340 | $39,334,000 | 6.13% |
| FRAZIER MANAGEMENT LLC | 2,188,331 | $24,619,000 | 4.51% |
| Prosight Management, LP | 715,317 | $8,047,000 | 4.49% |
| Avoro Capital Advisors LLC | 8,662,720 | $97,456,000 | 4.48% |
| QVT Financial LP | 821,361 | $8,748,000 | 2.26% |
| Perceptive Advisors | 7,290,199 | $82,014,000 | 2.19% |
| Rhenman & Partners Asset Management AB | 1,290,495 | $14,518,000 | 1.46% |
| EMORY UNIVERSITY | 185,915 | $2,092,000 | 1.37% |